Press Releases Archives - Page 6 of 103 - Lupin

BSE 2300.00 NSE 2307.90

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2300.00 NSE 2307.90

Lupin Foundation Flags off Mobile Medical Van in Palghar to Strengthen Non-Communicable Disease Care

Lupin Receives Tentative Approval from U.S. FDA for Oxcarbazepine ER Tablets

Lupin Announces Presentation of Phase 1 Data on LNP7457 (PRMT5 inhibitor) at the American Society of Clinical Oncology – Annual Meeting 2025

Lupin and SteinCares Enter into License and Supply Agreement for Ranibizumab in Latin America

Lupin and Honeywell Move Forward Jointly with Plans for HFO Technology in Inhalers

Punita Lal Joins Lupin Board as Additional Director

Lupin Receives Approval from U.S. FDA for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg

Lupin FY2025 Results

Lupin Launches Tolvaptan Tablets in the U.S. with 180-Day Exclusivity

Lupin Receives Approval from U.S. FDA for Raltegravir Tablets USP, 600 mg

1 2 … 5 6 7 … 102 103

Search

Hit enter to search or ESC to close